KDST.TA
Kadimastem Ltd
Price:  
2,604.00 
ILS
Volume:  
48,186.00
Israel | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KDST.TA WACC - Weighted Average Cost of Capital

The WACC of Kadimastem Ltd (KDST.TA) is 9.1%.

The Cost of Equity of Kadimastem Ltd (KDST.TA) is 10.40%.
The Cost of Debt of Kadimastem Ltd (KDST.TA) is 5.00%.

Range Selected
Cost of equity 9.00% - 11.80% 10.40%
Tax rate 0.70% - 0.90% 0.80%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.1% - 10.2% 9.1%
WACC

KDST.TA WACC calculation

Category Low High
Long-term bond rate 4.8% 5.3%
Equity market risk premium 6.1% 7.1%
Adjusted beta 0.68 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.00% 11.80%
Tax rate 0.70% 0.90%
Debt/Equity ratio 0.3 0.3
Cost of debt 5.00% 5.00%
After-tax WACC 8.1% 10.2%
Selected WACC 9.1%

KDST.TA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for KDST.TA:

cost_of_equity (10.40%) = risk_free_rate (5.05%) + equity_risk_premium (6.60%) * adjusted_beta (0.68) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.